FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210753974> ?p ?o ?g. }

• W4210753974 abstract "Abstract Background In autologous stem cell transplant (ASCT) for lymphomas, no standard conditioning regimen has been defined so far. Thus, the choice is guided by the center's familiarity and experience with a particular regimen. Objective To determine the response, toxicity, and survival outcomes in lymphoma patients who underwent ASCT with CBV (cyclophosphamide, carmustine, and etoposide) conditioning regimen. Materials and Methods Between January 2013 and May 2019, 45 consecutive lymphoma patients who had ASCT with CBV conditioning regimen were included in this retrospective study. CBV consisted of cyclophosphamide (1.5 g/m2/day × 4 days), carmustine (300 mg/m2 × 1 day), and etoposide (125 mg/m2 twice daily × 3 days). Baseline characteristics, pre transplant response, apheresis, post-transplant toxicities, post-transplant response, and survival outcomes were collected. Endpoints were toxicity, response, event-free survival (EFS), and overall survival (OS). Results The median age was 30 (range: 6–64) years. Diagnosis was Hodgkin lymphoma (HL) in 26 (58%) and non-Hodgkin lymphoma (NHL) in 19 (42%). Forty-three patients (95%) had chemosensitive disease; 22(49%) in CR, and 21 (46%) in PR. The median CD34 was 2.95 × 106/kg (range: 0.9–9.56). The median time to neutrophil engraftment was 11 days (9–23) and 13 (8–36) days for platelets. All patients had febrile neutropenia, clinically and/or microbiologically documented infection was seen in 75% of patients. The most common grade 3/4 toxicities were mucositis (n = 4, 9%), diarrhea (n = 4, 9%), and nausea/vomiting (n = 2, 4%). The average days of hospitalization was 18 (range: 10–37). Day 100 mortality was 6.6% (n = 3). The median follow-up was 44.8 months. The median EFS for the entire cohort was 23.8 months; for HL, the median EFS was not reached, and for NHL, it was 7.97 months (95% confidence interval [CI]: 1.57–14.37). The median OS for the entire cohort and for HL was not reached; for NHL, it was 24.3 months (95% CI: 0.56–48.11). Conclusion CBV conditioning regimen was well tolerated with low grade 3/4 toxicities and efficacy comparable to literature data." @default.
• W4210753974 created "2022-02-08" @default.
• W4210753974 creator A5003781176 @default.
• W4210753974 creator A5004304550 @default.
• W4210753974 creator A5018695873 @default.
• W4210753974 creator A5018712940 @default.
• W4210753974 creator A5034169965 @default.
• W4210753974 creator A5040646551 @default.
• W4210753974 creator A5043046052 @default.
• W4210753974 creator A5058623117 @default.
• W4210753974 creator A5070140951 @default.
• W4210753974 date "2022-02-02" @default.
• W4210753974 modified "2023-09-27" @default.
• W4210753974 title "Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India" @default.
• W4210753974 cites W1954992673 @default.
• W4210753974 cites W1997353354 @default.
• W4210753974 cites W2000142787 @default.
• W4210753974 cites W2024626926 @default.
• W4210753974 cites W2026325502 @default.
• W4210753974 cites W2041081497 @default.
• W4210753974 cites W2044804132 @default.
• W4210753974 cites W2063553062 @default.
• W4210753974 cites W2064378168 @default.
• W4210753974 cites W2067670674 @default.
• W4210753974 cites W2073402239 @default.
• W4210753974 cites W2074157250 @default.
• W4210753974 cites W2075816749 @default.
• W4210753974 cites W2078150969 @default.
• W4210753974 cites W2085343700 @default.
• W4210753974 cites W2170117191 @default.
• W4210753974 cites W2231181526 @default.
• W4210753974 cites W2324142404 @default.
• W4210753974 cites W2411938662 @default.
• W4210753974 cites W2571990569 @default.
• W4210753974 cites W2763648391 @default.
• W4210753974 cites W2884498204 @default.
• W4210753974 cites W2894880117 @default.
• W4210753974 doi "https://doi.org/10.1055/s-0041-1740134" @default.
• W4210753974 hasPublicationYear "2022" @default.
• W4210753974 type Work @default.
• W4210753974 citedByCount "0" @default.
• W4210753974 crossrefType "journal-article" @default.
• W4210753974 hasAuthorship W4210753974A5003781176 @default.
• W4210753974 hasAuthorship W4210753974A5004304550 @default.
• W4210753974 hasAuthorship W4210753974A5018695873 @default.
• W4210753974 hasAuthorship W4210753974A5018712940 @default.
• W4210753974 hasAuthorship W4210753974A5034169965 @default.
• W4210753974 hasAuthorship W4210753974A5040646551 @default.
• W4210753974 hasAuthorship W4210753974A5043046052 @default.
• W4210753974 hasAuthorship W4210753974A5058623117 @default.
• W4210753974 hasAuthorship W4210753974A5070140951 @default.
• W4210753974 hasBestOaLocation W42107539741 @default.
• W4210753974 hasConcept C126322002 @default.
• W4210753974 hasConcept C141071460 @default.
• W4210753974 hasConcept C2776694085 @default.
• W4210753974 hasConcept C2776755627 @default.
• W4210753974 hasConcept C2777063308 @default.
• W4210753974 hasConcept C2778119113 @default.
• W4210753974 hasConcept C2778496288 @default.
• W4210753974 hasConcept C2778850193 @default.
• W4210753974 hasConcept C2780147359 @default.
• W4210753974 hasConcept C2781413609 @default.
• W4210753974 hasConcept C2911091166 @default.
• W4210753974 hasConcept C71924100 @default.
• W4210753974 hasConcept C90924648 @default.
• W4210753974 hasConceptScore W4210753974C126322002 @default.
• W4210753974 hasConceptScore W4210753974C141071460 @default.
• W4210753974 hasConceptScore W4210753974C2776694085 @default.
• W4210753974 hasConceptScore W4210753974C2776755627 @default.
• W4210753974 hasConceptScore W4210753974C2777063308 @default.
• W4210753974 hasConceptScore W4210753974C2778119113 @default.
• W4210753974 hasConceptScore W4210753974C2778496288 @default.
• W4210753974 hasConceptScore W4210753974C2778850193 @default.
• W4210753974 hasConceptScore W4210753974C2780147359 @default.
• W4210753974 hasConceptScore W4210753974C2781413609 @default.
• W4210753974 hasConceptScore W4210753974C2911091166 @default.
• W4210753974 hasConceptScore W4210753974C71924100 @default.
• W4210753974 hasConceptScore W4210753974C90924648 @default.
• W4210753974 hasLocation W42107539741 @default.
• W4210753974 hasOpenAccess W4210753974 @default.
• W4210753974 hasPrimaryLocation W42107539741 @default.
• W4210753974 hasRelatedWork W1858470829 @default.
• W4210753974 hasRelatedWork W2002669147 @default.
• W4210753974 hasRelatedWork W2053223574 @default.
• W4210753974 hasRelatedWork W2308168543 @default.
• W4210753974 hasRelatedWork W2343642485 @default.
• W4210753974 hasRelatedWork W2408567797 @default.
• W4210753974 hasRelatedWork W2563189124 @default.
• W4210753974 hasRelatedWork W2989639282 @default.
• W4210753974 hasRelatedWork W3216526221 @default.
• W4210753974 hasRelatedWork W2470307162 @default.
• W4210753974 isParatext "false" @default.
• W4210753974 isRetracted "false" @default.
• W4210753974 workType "article" @default.